Syntheses, crystal structures and anticancer activities of three novel transition metal complexes with Schiff base derived from 2-acetylpyridine and l-tryptophan

Inorganic Chemistry Communications

Volumn 22, Issue , 2012, Pages 68-72

  Zhang, Nan ^a   Fan, Yu Hua ^a   Zhang, Zhen ^a   Zuo, Jian ^a   Zhang, Peng Fei ^a   Wang, Qiang ^a   Liu, Shan Bin ^a   Bi, Cai Feng ^a  

^a Ocean University of China   (China)

Author keywords

2 acetylpyridine; Anticancer activity; Crystal structure; l tryptophan; Schiff base

Indexed keywords

EID: 84863313868     PISSN: 13877003     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.inoche.2012.05.022     Document Type: Article

References (30)

1. Y. Sunatsuki, Y. Motoda, and N. Matsumoto Copper(II) complexes with multidentate Schiff-base ligands containing imidazole groups: ligand-complex or self-complementary molecule Coord. Chem. Rev. 226 2002 199 209
2. R. Ziessel Unusual coordination features and mesomorphic behaviour Coord. Chem. Rev. 216-217 2001 195 223
3. S. Yamada Advancement in stereochemical aspects of Schiff base metal complexes Coord. Chem. Rev. 190-192 1999 537 555
4. E. Kimura, S. Wada, M. Shiyonoya, and Y. Okazaki New series of multifunctionalized nickel(II)-cyclam (cyclam = 1,4,8,11- tetraazacyclotetradecane) complexes. Application to the photoreduction of carbon dioxide Inorg. Chem. 96 1994 770 778
5. II complexes Inorg. Chem. 21 1982 68 72
6. M.L. Munzarova, and M.A. Kaupp A density functional study of EPR parameters for vanadyl complexes containing Schiff base ligands J. Phys. Chem. B 105 2001 12644 12652
7. B.A. Teicher, M.J. Abrams, and K.W. Rosbe Cytotoxicity, radiosensitization, antitumor activity and interaction with hyperthermia of a cobalt(III) mustard complex Cancer Res. 50 1990 6971 6975
8. K. Srinivasn, K. Shankaranarayanan, S. Thangavelu, and P. Ramasamy Influence of organic solvents on the habit of NMBA (4-nitro-4'-methylbenzylidene aniline) crystals Cryst. Growth 212 2000 246 254
9. P.V. Rao, E. Wegelius, C.P. Rao, and K. Rissanen 2-Hydroxy-1- naphtaldehyde-derived Schiff bases: Synthesis, characterization and structure J. Chem. Crystallogr. 33 2003 139 147
10. 2 -· of β-phenylalanine Schiff base binuclear complexes Russ. J. Coord. Chem. 34 2008 772 774
11. M.J. Abrams, and B.A. Murrer Metal compounds in cancer therapy and diagnosis Science 261 1993 725 730
12. J. Adams, V.J. Palombella, and E.A. Sausville Proteasome inhibitors: a novel class of potent and effective antitumor agents Cancer Res. 59 1999 2615 2622
13. R.Z. Orlowski, T.E. Stinchcombe, and B.S. Mitchell Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies J. Clin. Oncol. 20 2002 4420 4427
14. J.A. Dams Potential for proteasome inhibition in the treatment of cancer Drug Discov. Today 8 2003 307 315
15. J.B. Almond, and G.M. Cohen The proteasome: a novel target for cancer chemotherapy Leukemia 16 2002 433 443
16. Q.P. Dou, and B. Li Pharmacological proteasome inhibitors and their therapeutic potential Expert. Opin. Ther. Pat. 10 2000 1263 1272
17. B. Cvek, V. Milacic, J. Taraba, and Q.P. Dou Ni(II), Cu(II), and Zn(II) Diethyldithiocarbamate complexes show various activities against the proteasome in breast cancer cells J. Med. Chem. 51 2008 6256 6258
18. V. Milacic, D. Chen, L. Giovagnini, A. Diez, D. Fregona, and Q.P. Dou Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity Toxicol. Appl. Pharmacol. 231 2008 23 24
19. L.H. Li, H.J. Yang, D. Chen, C. Cui, and Q.P. Dou Disulfiram promotes the conversion of carcinogen cadmium to a proteasome inhibitor with pro-apoptotic activity in human cancer cell Toxicol. Appl. Pharmacol. 229 2008 206 214
20. G.M. Sheldrick SHELXTL-97 1997 Program for Crystal Structure Refinement University of Göttingen, Germany
21. Y.H. Fan, Y.F. Wang, C.F. Bi, Q. Wang, X. Zhang, and X. Liu Synthesis, crystal structure, and fluorescence properties of a two-dimensional copper(II) complex with Schiff base Russ. J. Coord. Chem. 36 2010 509 513
22. Q. Wang, C.F. Bi, Y.H. Fan, X. Zhang, J. Zuo, and S.B. Liu A novel copper(II) complex with Schiff base derived from o-vanillin and L-methionine: Synthesys and crystal structure Russ. J. Coord. Chem. 37 2011 228 234
23. F. Arslan, M. Odabasoglu, H. Oelmez, and O. Büyükgü ngör Synthesis, crystal structure, spectral and thermal characterization of bis(o-vanillinato)- triethyleneglycoldiiminecopper(II) and bis[(R)-(-)- hydroxymethylpropylimine o-vanillinato]copper(II) Polyhedron 28 2009 2943 2948
24. N. Zhang, Y.H. Fan, C.F. Bi, J. Zuo, and Q. Wang Synthesis and crystal structure of a new nickel(II) coordination polymer based on Schiff base Russ. J. Coord. Chem. 38 2012 349 352
25. K.G. Daniel, D. Chen, S. Orlu, Q.C. Cui, F.R. Miller, and Q.P. Dou Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells Breast Cancer Res. 7 2005 897 908
26. K. Bielawski, A. Bielawska, B. Poplawska, A. Surazynski, and R. Czarnomysy The effect of novel dinuclear platinum complex with berenil and 2-picoline ligands on growth of human breast cancer cells Acta Pol. Pharm. Drug Res. 67 2010 609 614
27. B. An, R.H. Goldfarb, R. Siman, and Q.P. Dou Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclindependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts Cell Death Differ. 5 1998 1062 1075
28. H.C. Drexler Activation of the cell death program by inhibition of proteasome function Proc. Natl. Acad. Sci. U.S.A. 94 1997 855 860
29. U.G. Lopes, P. Erhardt, R. Yao, and G.M. Cooper p53-dependent induction of apoptosis by proteasome inhibitors J. Biol. Chem. 272 1997 12893 12896
30. H.J. Yang, D. Chen, Q.C. Cui, X. Yuan, and Q.P. Dou Celastrol, a Triterpene extracted from the Chinese Thunder of God Vine, is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice Cancer Res. 66 2006 4758 4765